A global leader in minimally invasive aesthetic technologies, the company develops and markets advanced medical devices for body contouring, skin tightening, and facial treatments. Its innovative solutions, such as radiofrequency-assisted lipolysis, have gained traction among clinicians and patients, driving consistent revenue growth and investor interest.
1 member of Congress has disclosed 3 trades in InMode Ltd. (INMD), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| 2019-11-15 | Tom Rice | buy | $1K – $15K |